You can buy or sell D. R. Horton and other stocks, options, ETFs, and crypto commission-free!
D.R. Horton, Inc. operates as a national homebuilder that engages in the construction and sale of single-family housing. Read More It operates through the Homebuilding and Financial Services segments. The Homebuilding segment includes the sub-segments East, Midwest, Southeast, South Central, Southwest, and West regions. The Financial Services segment provides mortgage financing and title agency services to homebuyers in many of its homebuilding markets. The company was founded by Donald Ray Horton in 1978 and is headquartered in Arlington, TX.
52 Week High
52 Week Low
Present Performance: D.R. Horton (NYSE: DHI)
D.R. Horton is in the homebuilding and construction industry and is in the consumer cyclical sector. D.R. Horton Inc is a residential homebuilder. It constructs for the purpose of sale, homes in the states and metropolitan markets of the United States, under the names of D.R. Horton, America’s Builder, Emerald Homes and Breland Homes. Previous Intraday Trading Performance: The DHI stock showed a previous change of -0.10% with an open at 41.02 and a close of 40.76. It reached an intraday high of 41.53 and ...
Simply Wall StMar 15
An Examination Of D.R. Horton, Inc. (NYSE:DHI)
As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean, I look at stocks holistically, from their financial health to their future outlook. In the case of D.R. Horton, Inc. (NYSE:DHI), it is a financially-sound , dividend-paying company with a a great history of performance. Below is a brief commentary on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on D.R. Horton here. Solid track record...
3 Big Stock Charts for Tuesday: D. R. Horton, PPL and CF Industries
It could have been worse. Though the S&P 500 ended Monday’s trade down 0.39%, at one point in the session the index was off by as much as 1.3% on renewed concerns about the ongoing tariff war with China. Salesforce.com (NYSE: CRM ) did the most damage, falling 3.7% after offering disappointing guidance for the year now underway. Eli Lilly (NYSE: LLY ) chipped in too, however, losing 1.1% of its value on news that it was cutting the price of its insulin injection, Humalog, by half as a measure to quell crit...
Expected Apr 25, Pre-Market